- Home
- / Orchestra BioMed
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Orchestra BioMed financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$6.1
2024-10-29
Market Capitalization
$231.9 M
2024-10-29
Revenue
$33.5 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 13, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 2.8M | 2.6M | 33.5M | ||
| Cost of goods sold | 186.0K | 204.0K | 190.0K | ||
| Gross profit | 2.6M | 2.4M | 33.3M | ||
| Gross profit margin, % | 93.3% | 92.3% | 99.4% | ||
| General and administrative expense | 3.0M | 20.3M | 23.9M | 26.9M | |
| Operating expense total | 3.0M | 54.1M | 66.7M | 85.1M | |
| EBIT | (3.1M) | (51.5M) | (64.3M) | (51.8M) | |
| EBIT margin, % | -1866.2% | -2437.5% | -154.7% | ||
| Interest income | 345.1K | ||||
| Interest expense | 1.4M | 297.0K | 1.1M | ||
| Net Income | (2.7M) | (49.1M) | (61.0M) | (52.7M) | |
| EPS | (0.2) | (1.5) | (1.7) | (1.1) |